ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

124
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
14 Jul 2025 01:14

Merger Arb Mondays (14 Jul) - Shibaura, Topcon, Nissin, OneConnect, Insignia, PointsBet, ENN Energy

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
726 Views
Share
bullishJohns Lyng
13 Jul 2025 06:15

(Mostly) Asia-Pac M&A: Johns Lyng, New World Resources, Oneconnect, Great Eastern, VIOL

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
412 Views
Share
07 Jul 2025 06:15

Fengxiang (9977 HK): Composite Doc Out. 24th July H-Class Meeting

This is done. But this is an illiquid arb - and Hong Kong has seen two failed small-cap Schemes recently. Plus PAG is inviting dissent after...

Logo
316 Views
Share
07 Jul 2025 01:21

Merger Arb Mondays (07 Jul) - Seven & I, Shibaura, Insignia, New World, ENN Energy, HKBN, Fengxiang

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
898 Views
Share
bullishLens Technology
06 Jul 2025 15:46

Weekly Deals Digest (06 Jul) - Lens Tech, FWD, Geekplus, NTT DC REIT, Fengxiang, HKBN, Insignia

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
534 Views
Share
x